On a blood film, B cells, T cells, and natural killer cells all look like small lymphocytes, and antigen-specific IgM in a newborn is interpreted differently from IgG. Interpreting results like these requires an understanding of how the immune system is organized. Immune defense combines rapid recognition by barriers, phagocytes, and soluble mediators with the specific receptors and memory of lymphocytes. Laboratory findings reflect where an immune response began, which cells were recruited, how antigen was presented, and which immunoglobulin class the responding B-cell clone produced.1,2
Innate and adaptive immunity
Innate immunity responds within minutes to hours through epithelial barriers, phagocytes, natural killer (NK) cells, complement, cytokines, and germline-encoded receptors that recognize conserved microbial or tissue-injury patterns. These signals limit early injury and help determine where and how lymphocytes respond.
Adaptive immunity uses B-cell receptors (BCRs) and T-cell receptors (TCRs) assembled during lymphocyte development. Each clone has a narrow receptor specificity. Antigen selects matching clones to proliferate into short-lived effector cells and longer-lived memory cells. The first response develops gradually. Later exposure can recruit memory cells quickly and generate a larger, more sustained response.1,2
Scroll sideways to see all columns
| Feature | Innate response | Adaptive response |
|---|---|---|
| Recognition | Conserved microbial and damage patterns | Individual antigen epitopes |
| Main cells | Neutrophils, eosinophils, basophils, monocytes and macrophages, dendritic cells, mast cells, and NK cells | B lymphocytes, plasma cells, and T lymphocytes |
| Receptor source | Germline-encoded pattern-recognition receptors | Somatically rearranged BCR and TCR genes |
| First response | Rapid | Develops after antigen recognition, activation, and clonal expansion |
| Later response | Can be altered by trained innate states (lasting changes after prior activation)3 | Antigen-specific memory produces faster and stronger recall responses |
The innate and adaptive branches operate as one system. Dendritic cells carry captured antigen to lymphoid tissue, complement can mark antigen for B-cell recognition, helper T cells direct B-cell and macrophage activity, and antibodies recruit phagocytes, NK cells, and complement.
Immune cells and laboratory identification
Circulating leukocyte morphology provides clues to cell type. Flow cytometry identifies lineage and maturation through combinations of cluster of differentiation (CD) markers. The same CD antigen can occur on several cell types, and its expression can change during maturation. Interpret each marker within the full panel, together with the specimen and clinical setting, because one CD antigen alone does not identify a lineage.1,5
All leukocyte lineages develop from hematopoietic stem cells in bone marrow. A common teaching model divides their descendants into myeloid-biased progenitors for granulocytes and monocytes and lymphoid-biased progenitors for B, T, and NK cells. Human hematopoiesis follows a more continuous set of overlapping developmental states, and dendritic cells can arise through more than one route.6
Scroll sideways to see all columns
| Cell | Recognition in the laboratory | Principal immune function |
|---|---|---|
| Neutrophil | Segmented nucleus and fine, pale granules | Rapid migration, phagocytosis, oxidative killing, and granule release during acute inflammation |
| Eosinophil | Usually bilobed nucleus with large orange-red granules | Helminth defense and type 2 inflammatory responses |
| Basophil | Coarse, dark blue-purple granules that can obscure the nucleus | Histamine and other mediator release during allergic and type 2 inflammation |
| Monocyte and macrophage | Circulating monocytes have a folded nucleus and gray-blue cytoplasm; tissue macrophages are larger and often vacuolated | Phagocytosis, cytokine release, tissue cleanup, and antigen presentation |
| Dendritic cell | Specialized morphology varies by tissue; identification uses context and phenotype | Antigen capture and efficient priming of naïve T cells |
| Mast cell | Tissue cell with dense metachromatic granules | High-affinity IgE binding and mediator release after receptor cross-linking |
| Small lymphocyte | Dense, round to slightly indented nucleus with a thin rim of pale cytoplasm | B, T, and NK populations share this appearance and require immunophenotyping for separation |
| Plasma cell | Eccentric nucleus with clumped clock-face chromatin, deeply basophilic cytoplasm, and a pale Golgi zone | High-rate secretion of one immunoglobulin specificity |
Common lineage-associated marker patterns include:
Scroll sideways to see all columns
| Population | Useful marker pattern | Interpretation limit |
|---|---|---|
| Mature T cells | CD3 with TCR; CD4 or CD8 on major subsets | CD4 and CD8 also occur outside their best-known T-cell subsets |
| B-lineage cells | CD19 with stage-dependent CD20 and CD21 | Plasma-cell differentiation commonly reduces CD20 and increases CD138 |
| NK cells | CD3-negative with CD56 and/or CD16 expression | Other leukocyte populations can express CD16 and CD56, so a panel is required |
| Plasma cells | Bright CD38 and CD138 with cytoplasmic immunoglobulin | Reactive and clonal plasma cells require additional markers and light-chain assessment |
CD16 is FcγRIII and supports antibody-dependent cellular cytotoxicity by NK cells. CD21 is complement receptor 2, which binds C3d-coated antigen and participates in the B-cell coreceptor complex. CD3 transmits TCR signals into the T cell. CD4 and CD8 stabilize recognition of major histocompatibility complex (MHC) class II and class I, respectively.1,5
Lymphoid organs and lymphocyte development
Primary lymphoid organs are sites of antigen-independent development. Secondary lymphoid organs bring mature lymphocytes together with antigen and activating signals.1,2
Scroll sideways to see all columns
| Organ group | Sites | Main function |
|---|---|---|
| Primary | Bone marrow and thymus | B-cell development in marrow and T-cell development in the thymus |
| Secondary | Lymph nodes, spleen, and mucosa-associated lymphoid tissue | Antigen capture, lymphocyte activation, clonal expansion, and generation of effector and memory cells |
Lymph nodes filter lymph arriving from tissues. B-cell follicles occupy the cortex. T cells and antigen-presenting dendritic cells concentrate in the paracortex. An activated follicle can form a germinal center where B cells undergo somatic hypermutation, affinity selection, and class switching. The spleen performs this surveillance for blood-borne antigen. Its red pulp removes aged blood cells and particles. White-pulp T-cell zones and B-cell follicles surround central arterioles. The marginal zone captures blood-borne antigen and contains specialized B cells and macrophages. Mucosa-associated lymphoid tissue protects respiratory, gastrointestinal, and urogenital surfaces. Cutaneous-associated lymphoid tissue provides immune surveillance in skin.1
The thymus lies in the anterior mediastinum. Developing thymocytes move through cortical and medullary environments while the TCR genes rearrange and self-reactive cells are controlled. Selection occurs across overlapping thymic regions and involves cortical and medullary thymic epithelial cells, dendritic cells, and macrophages.9
Scroll sideways to see all columns
| T-cell stage | CD4 and CD8 pattern | Receptor and selection event |
|---|---|---|
| Double negative | CD4-negative, CD8-negative | TCR β-chain rearrangement begins; a productive β chain supports further development |
| Double positive | CD4-positive, CD8-positive | TCR α-chain rearrangement completes the αβ receptor; positive selection preserves cells that recognize self-MHC with suitable strength |
| Single positive | CD4-positive or CD8-positive | Strongly self-reactive cells are often deleted; a subset of CD4 thymocytes enters the regulatory T-cell lineage; surviving cells leave as mature naïve T cells |
Recognition of MHC class II usually commits a cell to the CD4 lineage, and recognition of MHC class I usually commits it to the CD8 lineage. γδ T cells form a smaller lineage with distinct receptor, selection, and tissue-distribution patterns.
A productive TCR β-chain signal suppresses further β-chain rearrangement, a process called allelic exclusion. α-chain rearrangement can continue until selection succeeds. These steps help each conventional T-cell clone express a defined receptor specificity.9
B-cell development begins in bone marrow with ordered heavy-chain and light-chain gene rearrangement. A productive μ heavy chain first pairs with a surrogate light chain to form the pre-BCR. Light-chain rearrangement then completes surface IgM. Strong recognition of self can lead to receptor editing, deletion, or functional silencing. Surviving mature naïve B cells usually coexpress surface IgM and IgD with the same antigen specificity.1
Scroll sideways to see all columns
| B-cell stage | Representative phenotype | Developmental event |
|---|---|---|
| Pro-B cell | CD19 with stage-dependent CD10 | Heavy-chain D-J and then V-DJ rearrangement |
| Pre-B cell | CD19 and CD20 with cytoplasmic μ chain | Productive μ chain pairs with surrogate light chain; heavy-chain allelic exclusion follows |
| Immature B cell | Surface IgM with CD19 and CD20 | Light-chain rearrangement completes the BCR; central-tolerance checkpoints test self-reactivity |
| Mature naïve B cell | Surface IgM and IgD with CD19, CD20, and CD21 | Cells enter follicles or the splenic marginal zone and await antigen |
| Plasma cell | CD38 and CD138 with abundant cytoplasmic immunoglobulin | Terminal differentiation supports high-rate antibody secretion |
Kappa light-chain rearrangement usually begins before lambda. Receptor editing can reopen light-chain rearrangement when an immature BCR reacts strongly with self. Marker intensity varies with tissue, maturation, activation, disease, and assay. Interpret these phenotypes as one part of a lineage panel.1,5
Antigen presentation and lymphocyte activation
T cells recognize peptides displayed by MHC. B cells recognize intact antigen through surface immunoglobulin. This difference determines how each cell type is recruited into an immune response.
Scroll sideways to see all columns
| Presentation route | Usual peptide source | Responding T cell | Main consequence |
|---|---|---|---|
| MHC class I | Proteins made within the cell, including viral and tumor proteins | CD8 T cell | Cytotoxic effector development and killing of cells displaying the peptide |
| MHC class II | Material captured from outside the presenting cell | CD4 T cell | Helper programs that direct macrophages, B cells, and other leukocytes |
Some dendritic cells use cross-presentation to place captured extracellular antigen on MHC class I. This route helps prime CD8 T cells against viral or tumor antigens acquired from other cells.1
Naïve T-cell activation requires three linked inputs: TCR recognition of peptide-MHC, costimulation such as CD80 or CD86 binding CD28, and cytokines that shape differentiation. Dendritic cells upregulate costimulatory molecules as they mature in response to inflammatory and innate signals. Antigen recognition with inadequate costimulation can lead to anergy or another nonproductive tolerant state.
Scroll sideways to see all columns
| T-cell program | Markers and mediators | Main function |
|---|---|---|
| Th1 | Interferon gamma | Activates macrophage and cell-mediated responses against intracellular organisms |
| Th2 | Interleukins 4, 5, and 13 | Supports helminth defense, eosinophils, IgE production, and allergic inflammation |
| Th17 | Interleukins 17 and 22 | Promotes mucosal defense and neutrophil recruitment against extracellular bacteria and fungi |
| Regulatory T cell | FOXP3, CD25, IL-10, and TGF-β associations | Limits self-reactive and excessive immune responses |
| Follicular helper T cell | CD40 ligand and IL-21 among its signals | Supports germinal-center B-cell selection, class switching, and memory |
| Cytotoxic T cell | Perforin, granzymes, and Fas ligand | Induces apoptosis in peptide-MHC class I-bearing target cells |
These helper-cell programs can overlap or change with the cytokine environment. NK cells use a different recognition system that integrates activating and inhibitory signals from stressed, infected, or transformed cells. NK-cell CD16 can also bind IgG-coated targets and trigger antibody-dependent cellular cytotoxicity.1
B-cell activation and antibody responses
A T-dependent response begins when a B cell binds a protein antigen through its BCR, internalizes it, and presents a peptide on MHC class II. A follicular helper T cell that recognizes the peptide provides CD40 ligand signaling and cytokines. Activated B cells can become early plasma cells or enter a germinal center, where activation-induced cytidine deaminase supports class-switch recombination and somatic hypermutation. Selection of stronger-binding variants produces affinity maturation, and some progeny become memory B cells or long-lived plasma cells.1
Repetitive polysaccharides and other multivalent antigens can activate B-1 and splenic marginal-zone B cells with limited direct T-cell help. These responses are commonly dominated by IgM and show less germinal-center maturation, class switching, and durable recall than protein responses. Conjugating a polysaccharide to a carrier protein recruits T-cell help and improves immunologic memory, which explains the different behavior of polysaccharide and conjugate vaccines.12
Scroll sideways to see all columns
| Feature | Primary response | Secondary response |
|---|---|---|
| Exposure | First encounter with an antigen | Later encounter with the same antigen |
| Cells available at the start | Rare naïve antigen-specific clones | Memory B and T cells plus established long-lived plasma-cell output |
| Typical antibody pattern | IgM often appears before substantial class-switched antibody | Class-switched antibody commonly rises sooner and to a higher concentration |
| Binding strength | Early antibodies have lower average affinity | Affinity-matured memory clones produce higher-average-affinity antibody |
| Duration | Contracts after the antigen is cleared, and memory remains | Commonly larger and more sustained |
The timing and isotype pattern depend on the antigen, route of exposure, vaccination history, host factors, and assay. Infectious-disease serology therefore uses organism-specific marker timelines and validated criteria for seroconversion or change in paired titers.
Immunoglobulin structure
A conventional immunoglobulin monomer is a disulfide-linked unit with two identical heavy chains and two identical light chains. Each chain has a variable domain at its amino-terminal end and one or more constant domains. Each antigen-binding site forms from one heavy-chain variable domain paired with one light-chain variable domain. Six complementarity-determining region loops make up the binding surface, and the contribution of each loop varies by antibody and antigen.11
The heavy-chain constant region defines the immunoglobulin class and many effector interactions. Light chains are kappa or lambda. A single immunoglobulin molecule contains one light-chain type. The flexible hinge of IgG, IgA, and IgD allows the two antigen-binding arms to approach epitopes at different angles. IgM and IgE use an additional constant domain in place of the conventional IgG-like hinge arrangement. Glycosylation varies among classes and subclasses and can alter stability, complement recruitment, and Fc-receptor binding.
Proteolytic cleavage demonstrates the functional regions:
Scroll sideways to see all columns
| Treatment | Products | Laboratory meaning |
|---|---|---|
| Papain cleavage above the hinge | Two separate Fab fragments and one Fc fragment | Each Fab retains one antigen-binding site; Fc retains class-dependent effector interactions |
| Pepsin cleavage below the hinge | One linked F(ab')2 fragment with much of Fc degraded | Both antigen-binding arms remain connected, and most Fc activity is removed |
| Reduction of disulfide bonds | Separate heavy and light chains | Demonstrates the covalent links that stabilize the four-chain unit |
Three terms describe antigenic variation within immunoglobulins. Isotype identifies class- or subclass-defining constant-region features shared across the species. Allotype identifies inherited constant-region variants among individuals. Idiotype identifies variable-region antigenic features associated with one antibody specificity.1,11
Immunoglobulin classes and subclasses
The heavy-chain type defines each of the five major immunoglobulin classes. Each class has characteristic distribution and effector functions. The rearranged variable region preserves antigen specificity. The molecular masses and serum half-lives below are approximate values for the principal circulating form.1,11
Scroll sideways to see all columns
| Class | Usual secreted form | Approximate molecular mass | Typical serum half-life | Main distribution and function |
|---|---|---|---|---|
| IgG | Monomer | 150 kDa | About 21 days for most subclasses | Dominant serum antibody; neutralization, opsonization, Fc-receptor functions, and placental transfer through FcRn11,13 |
| IgM | J-chain-associated pentamer | About 970 kDa | About 5 days | Early antibody in many primary responses; efficient agglutination and classical complement activation; concentrated mainly in the vascular space11,13,14 |
| IgA | Serum monomer or secretory dimer with J chain and secretory component | 160 kDa as a monomer | About 6 days | Neutralizes organisms and toxins at mucosal surfaces and in secretions11,13 |
| IgD | Monomer | 180 kDa | About 3 days | Coexpressed with IgM as a BCR on mature naïve B cells11,13 |
| IgE | Monomer | 190 kDa | About 2 days while free in serum | Binds high-affinity FcεRI on mast cells and basophils; receptor cross-linking drives immediate hypersensitivity and contributes to helminth defense11,13 |
Subclass and receptor detail refines these class-level properties. IgG has four subclasses, and classical complement activation generally follows the order IgG3, IgG1, IgG2, with minimal IgG4 activity; IgG3 also commonly has a shorter half-life than the other subclasses. Monomeric IgM serves as the BCR. The secreted pentamer has ten theoretical antigen-binding sites, which is why it agglutinates so efficiently. IgA1 and IgA2 differ at the hinge, and the shorter IgA2 hinge resists cleavage by some bacterial proteases. IgD has limited serum abundance and few established effector roles. IgE bound to its high-affinity receptor persists far longer than the free serum antibody, so a short serum half-life does not limit sensitization.1,11
Placental FcRn transports IgG in physiologically important amounts. Transfer efficiency differs among subclasses and varies with gestational age, maternal concentration, placental function, and assay. IgG2 is commonly transferred less efficiently than the other subclasses.15
Secreted IgM has high avidity because several antigen-binding units can engage a repeated target at once. Effective valency depends on antigen spacing and access. Detection of antigen-specific IgM in a newborn supports fetal or neonatal synthesis because maternal IgM has negligible placental transfer. Confirm the result with organism-specific testing, and interpret it with the clinical picture.1,11
Mucosal plasma cells add a J chain when they assemble polymeric IgA. The epithelial polymeric immunoglobulin receptor transports that IgA across the cell. Its extracellular fragment remains on the released molecule as secretory component and helps protect the antibody from proteolysis.11
IgG1 is generally the most abundant IgG subclass, followed by IgG2, IgG3, and IgG4. Quantitative immunoglobulin concentrations and subclass distributions vary with age, population, assay, and clinical state. Interpret each result against the method- and age-specific reference interval.
Antibody diversity and monoclonal antibodies
Immunoglobulin genes occupy three major loci: the heavy-chain locus, IGH, on chromosome 14; the kappa light-chain locus, IGK, on chromosome 2; and the lambda light-chain locus, IGL, on chromosome 22. Heavy-chain variable regions assemble from V, D, and J gene segments. Light-chain variable regions assemble from V and J segments. Functional germline segments are present at each locus. A complete variable-region exon forms only after recombination in a developing B cell.16
Four processes expand the antibody repertoire:
- Combinatorial rearrangement selects one segment of each available V, D, and J type for a heavy chain and one V and J pair for a light chain.
- Junctional diversity adds or removes nucleotides where rearranged segments join.
- Heavy-light pairing combines independently assembled chains.
- Somatic hypermutation changes variable-region sequences after activation, followed by selection for stronger antigen binding.
Class-switch recombination places the existing rearranged variable region beside a different heavy-chain constant gene. The B-cell clone keeps its antigen specificity and gains a new effector class. Alternative RNA processing allows mature naïve B cells to express IgM and IgD with the same rearranged specificity.1,16
A polyclonal antiserum contains antibodies from several B-cell clones and can recognize several epitopes. A monoclonal antibody preparation contains one clonal or defined recombinant specificity. Monoclonal reagents can improve standardization and reproducibility. Their performance depends on the selected clone, target conformation, formulation, and assay conditions, so verify a new clone or reagent under your laboratory's procedure before it is used for patient testing.
Transfusion-specific effects of immunoglobulin class, antibody memory, agglutination, and complement are covered in Blood Group Immunology.
Practice
References
- Abbas AK, Lichtman AH, Pillai S, Henrickson S. Cellular and Molecular Immunology. 11th ed. Elsevier; 2025. Elsevier. Back to text
- National Institute of Allergy and Infectious Diseases. Overview of the immune system. National Institutes of Health. Reviewed December 30, 2013. Accessed August 29, 2026. Back to text
- Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20:375-388. doi:10.1038/s41577-020-0285-6 Back to text
- Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. The components of the immune system. In: Immunobiology: The Immune System in Health and Disease. 5th ed. Garland Science; 2001. Accessed September 7, 2026. Back to text
- Engel P, Boumsell L, Balderas R, et al. CD nomenclature 2015: human leukocyte differentiation antigen workshops as a driving force in immunology. J Immunol. 2015;195(10):4555-4563. doi:10.4049/jimmunol.1502033 Back to text
- Weng X, Wang M, Wang Q, et al. Deciphering cell states and genealogies of human haematopoiesis. Nature. 2024;627:389-398. doi:10.1038/s41586-024-07066-z Back to text
- College of American Pathologists. 2026 Hematology, Clinical Microscopy, and Body Fluids Glossary. 2026. Accessed September 7, 2026. https://www.cap.org/wp-content/uploads/documents/2026-Heme-Glossary-FINAL.pdf Back to text
- Li W. Flow cytometry in the diagnosis of leukemias. In: Li W, ed. Leukemia. Exon Publications; 2022. doi:10.36255/exon-publications-leukemia-flow-cytometry Back to text
- Ashby KM, Hogquist KA. A guide to thymic selection of T cells. Nat Rev Immunol. 2024;24:103-117. doi:10.1038/s41577-023-00911-8 Back to text
- Cano RLE, Lopera HDE. Introduction to T and B lymphocytes. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al, eds. Autoimmunity: From Bench to Bedside. El Rosario University Press; 2013. Accessed September 7, 2026. Back to text
- Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 suppl 2):S41-S52. doi:10.1016/j.jaci.2009.09.046 Back to text
- Kobayashi M, Farrar JL, Gierke R, et al. Pneumococcal vaccine for adults aged 19 years or older: recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep. 2023;72(3):1-39. doi:10.15585/mmwr.rr7203a1 Back to text
- Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Structural variation in immunoglobulin constant regions. In: Immunobiology: The Immune System in Health and Disease. 5th ed. Garland Science; 2001. Figure 4.16. Accessed September 7, 2026. Back to text
- Keyt BA, Baliga R, Sinclair AM, Carroll SF, Peterson MS. Structure, function, and therapeutic use of IgM antibodies. Antibodies (Basel). 2020;9(4):53. doi:10.3390/antib9040053 Back to text
- Pereira RA, de Almeida VO, Vidori L, Colvero MO, Amantéa SL. Immunoglobulin G and subclasses placental transfer in fetuses and preterm newborns: a systematic review. J Perinatol. 2023;43(1):3-9. doi:10.1038/s41372-022-01528-w Back to text
- IMGT, the international ImMunoGeneTics information system. Human immunoglobulin genes. Updated October 2, 2025. Accessed August 29, 2026. Back to text